Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride

Pharmaceutical Research

Volumn 21, Issue 12, 2004, Pages 2293-2299

  Upasani, Rashmi S ^a   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Iontophoresis; Response surface; Tacrine hydrochloride; Transdermal delivery

Indexed keywords

TACRINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; IN VITRO STUDY; IONTOPHORESIS; MATHEMATICAL MODEL; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY;

ANIMALS; DRUG DELIVERY SYSTEMS; IONTOPHORESIS; RATS; SKIN; SURFACE PROPERTIES; TACRINE;

EID: 17644379407     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-004-7682-6     Document Type: Article

References (21)

1. E. Heilbronn. Inhibition of cholinesterase by tetrahydroaminoacrin. Acta Chem. Scand. A 15:1386-1390 (1961).
2. G. W. Small. Tacrine for treating Alzheimer's disease. JAMA 268:2564-2565 (1992).
3. P. Hartvig, H. Askmark, S. M. Aquilonius, L. Wiklund, and B. Lindstrom. Clinical pharmacokinetics of intravenous and oral 9-amino-l,2,3,4- tetrahydroacridine, tacrine. Eur. J. Clin. Pharmacol 8:259-263 (1990).
4. G. Lou, P. R. Montgomery, and D. S. Sitar. Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease. J. Psychiatry Neurosci. 21:334-339 (1996).
5. T. Jaskari, M. Vuorio, K. Kontturi, A. Urtti, J. A. Manzanares, and G. Hirvonen. Controlled transdermal iontophoresis by ion-exchange fiber. J. Control. Rel. 67:179-190 (2000).
6. R. H. Guy, Y. N. Kalia, M. Begoña Delgado-Charro, V. Merino, A. López, and D. Marro. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Rel. 64:129-132 (2000).
7. A. Jadoul, J. Bouwstra, and V. Preat. Effect of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv. Drug Deliv. Rev. 35:89-105 (1999).
8. A. K. Banga. Electrically assisted transdermal and topical drug delivery, Taylor & Francis, London, 1998.
9. S. Nazzal and M. A. Khan. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS PharmSciTech 3(1) (2002), article 3.
10. A. V. Gore, A. C. Liang, and Y. W. Chien. Comparative biomembrane permeation of tacrine using Yucatan minipigs and domestic pigs as the animal model. J. Pharm. Sci. 87:441-447 (1998).
11. T. Kankkunen, R. Sulkava, M. Vuorio, K. Kontturi, and J. Hirvonen. Transdermal iontophoresis of tacrine in vivo. Pharm. Res. 19:704-707 (2002).
12. M. Al-Khalili, V. M. Meidan, and B. B. Michniak. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS PharmSci 5(2) (2003) article 14.
13. J. Hirvonen and R. H. Guy. Iontophoretic delivery across the skin: Electroosmosis and its Modulation by Drug Substances. Pharm. Res. 14:1258-1263 (1997).
14. A. Jadoul, J. Doucet, D. Durand, and V. Preat. Modifications induced on stratum corneum after in vitro iontophoresis: ATR-FTIR and X-ray scattering studies. J. Control. Rel. 42:165-173 (1996).
15. L. A. R. M. Pechtold, W. Abraham, and R. O. Potts. The influence of an electric field on ion and water accessibility to stratum corneum lipid lamellae. Pharm. Res. 13:1168-1173 (1996).
16. D. Marro, Y. N. Kalia, M. Begoña Delgado-Charro, and R. H. Guy. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18:1701-1708 (2001).
17. L. Wearley, J. Liu, and Y. W. Chien. Iontophoresis-facilitated transdermal delivery of verapamil I. In vitro evaluation and mechanistic studies. J. Control. Rel. 8:237-250 (1989).
18. N. Bellantone-Harper, S. Rim, M. Francoer, and B. Rasadi. Enhanced percutaneous absorption via iontophoresis. I. Evaluation of an in vitro system and transport of model compounds. Int. J. Pharm. 30:63-72 (1986).
19. R. H. Guy and J. Hadgraft. Rate control in transdermal drug delivery? Int. J. Pharm. 82:R1-R6 (1992).
20. A. J. Wagstaff and D. McTavish. Tacrine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging 4:510-540 (1994).
21. T. H. Park, K. H. Tachiki, W. K. Summers. D. Kling, J. Fitten, K. Ferryman, K. Spidell, and A. S. Kling. Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine. Anal Biochem. 159:358-362 (1986).